Thomas J. Garrity, Director at ANTARES PHARMA, INC. (AIS), bought 10,000 shares at $1.63 ($16K) on 2011-03-21, disclosed to the SEC on 2011-03-21.
Open-market purchase of $16k AIS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.58 | 7,000 | $11K | 69.3% |
| 2 | $1.63 | 3,000 | $5K | 30.7% |
| Total | $1.59 avg | 10,000 | $16K | 100% |
| Filing → |
| ATRS | SELL | 2021-01-13 | $284K | — | Filing → |
| ATRS | SELL | 2019-12-11 | $183K | — | Filing → |
| ATRS | SELL | 2019-05-03 | $80K | — | Filing → |